Cell Therapy Augments Myocardial Perfusion and Improves Quality of Life in Patients With Refractory Angina
- PMID: 26987911
- PMCID: PMC5180594
- DOI: 10.1161/CIRCRESAHA.116.308409
Cell Therapy Augments Myocardial Perfusion and Improves Quality of Life in Patients With Refractory Angina
Keywords: Editorial; angina; angiogenesis; meta-analysis; perfusion.
Figures
Comment on
-
Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.Circ Res. 2016 Mar 18;118(6):984-93. doi: 10.1161/CIRCRESAHA.115.308056. Epub 2016 Jan 13. Circ Res. 2016. PMID: 26838794 Free PMC article.
References
-
- Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA, Investigators AC Intramyocardial, autologous cd34+ cell therapy for refractory angina. Circulation research. 2011;109:428–436. - PMC - PubMed
-
- Kim MC, Kini A, Sharma SK. Refractory angina pectoris: Mechanism and therapeutic options. Journal of the American College of Cardiology. 2002;39:923–934. - PubMed
-
- Finci L, Meier B, Favre J, Righetti A, Rutishauser W. Long-term results of successful and failed angioplasty for chronic total coronary arterial occlusion. The American journal of cardiology. 1990;66:660–662. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical